Page last updated: 2024-10-19

phenethylamine and Peripheral Nerve Diseases

phenethylamine has been researched along with Peripheral Nerve Diseases in 1 studies

phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Concentrations of PEA in CSF in Parkinson's disease were significantly lower (mean 205 (SD 131) pg/ml) than in patients with peripheral neuropathy (433 (SD 254) pg/ml) and controls (387 (SD 194) pg/ml)."1.30Decreased beta-phenylethylamine in CSF in Parkinson's disease. ( Matsuishi, T; Shoji, H; Yamada, S; Zhou, G, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, G1
Shoji, H1
Yamada, S1
Matsuishi, T1

Other Studies

1 other study available for phenethylamine and Peripheral Nerve Diseases

ArticleYear
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:6

    Topics: Aged; Chromatography, Gas; Female; Homovanillic Acid; Humans; Levodopa; Male; Mass Spectrometry; Mid

1997